Anne Ortved Gang

2.7k total citations
59 papers, 969 citations indexed

About

Anne Ortved Gang is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Anne Ortved Gang has authored 59 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 29 papers in Oncology and 21 papers in Genetics. Recurrent topics in Anne Ortved Gang's work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Viral-associated cancers and disorders (10 papers). Anne Ortved Gang is often cited by papers focused on Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Viral-associated cancers and disorders (10 papers). Anne Ortved Gang collaborates with scholars based in Denmark, Sweden and Serbia. Anne Ortved Gang's co-authors include Marie K. Brimnes, Mette Ølgod Pedersen, Peter Nørgaard, Sine Reker Hadrup, Annette Juul Vangsted, Peter Gimsing, Inge Marie Svane, Lene Meldgaard Knudsen, Hans Erik Johnsen and Tim Svenstrup Poulsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Anne Ortved Gang

52 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Ortved Gang Denmark	15	447	428	346	234	198	59	969
Anna Guidetti Italy	18	355 0.8×	297 0.7×	182 0.5×	204 0.9×	121 0.6×	62	796
Keitaro Tsushita Japan	12	412 0.9×	429 1.0×	124 0.4×	219 0.9×	240 1.2×	25	818
Goretta Bonacorsi Italy	16	276 0.6×	215 0.5×	137 0.4×	135 0.6×	204 1.0×	34	710
Thai M. Cao United States	17	296 0.7×	149 0.3×	319 0.9×	164 0.7×	172 0.9×	48	866
Shinichi Makita Japan	16	403 0.9×	413 1.0×	143 0.4×	125 0.5×	114 0.6×	78	719
Martin Dreyling Germany	18	400 0.9×	376 0.9×	89 0.3×	292 1.2×	319 1.6×	63	938
Henry Januszewicz Australia	15	191 0.4×	356 0.8×	108 0.3×	115 0.5×	102 0.5×	23	644
Ilana Zalcberg Brazil	14	231 0.5×	196 0.5×	132 0.4×	246 1.1×	216 1.1×	53	739
Monika Klimkowska Sweden	15	223 0.5×	162 0.4×	383 1.1×	96 0.4×	95 0.5×	36	729
Caterina Fusco Italy	11	161 0.4×	309 0.7×	205 0.6×	114 0.5×	152 0.8×	22	616

Countries citing papers authored by Anne Ortved Gang

Since Specialization

Citations

This map shows the geographic impact of Anne Ortved Gang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Ortved Gang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Ortved Gang more than expected).

Fields of papers citing papers by Anne Ortved Gang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Ortved Gang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Ortved Gang. The network helps show where Anne Ortved Gang may publish in the future.

Co-authorship network of co-authors of Anne Ortved Gang

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Ortved Gang. A scholar is included among the top collaborators of Anne Ortved Gang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Ortved Gang. Anne Ortved Gang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schejbel, Lone, Anne Ortved Gang, Ib Jarle Christensen, et al.. (2024). TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real‐Word Patients With Primary Large B‐Cell Lymphoma. European Journal Of Haematology. 114(3). 573–579. 1 indexed citations

Sørum, Maria Ebbesen, Anne Ortved Gang, Dorte Tholstrup, et al.. (2024). Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study. BMJ Open. 14(10). e089862–e089862. 2 indexed citations

Hersby, Ditte Stampe, Mary Jarden, Torsten Holm Nielsen, et al.. (2024). Sexual health and testosterone concentration in male lymphoma survivors: A systematic review. Heliyon. 10(11). e31915–e31915. 1 indexed citations

Jakobsen, Lasse, Sandra Eloranta, Karin E. Smedby, et al.. (2024). Effectiveness of R‐CHOP versus R‐CHOEP for treatment of young patients with high‐risk diffuse large B‐cell lymphoma: A Danish observational population‐based study. European Journal Of Haematology. 113(5). 641–650. 2 indexed citations

Grauslund, Morten, Lene Dissing Sjø, Linea Cecilie Melchior, et al.. (2024). NOTCH1 Mutations Are Associated with Therapy-Resistance in Patients with B-Cell Lymphoma Treated with CD20xCD3 Bispecific Antibodies. Blood. 144(Supplement 1). 1594–1594. 1 indexed citations

Jakobsen, Lasse Hjort, Boris Modrau, Kristian Kragholm, et al.. (2023). Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study. Journal of Geriatric Oncology. 15(1). 101672–101672. 2 indexed citations

Nielsen, Torsten Holm, et al.. (2023). Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency. Annals of Hematology. 103(1). 227–239.

Jakobsen, Lasse Hjort, Kristian Kragholm, Joachim Bæch, et al.. (2023). Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study. Clinical Epidemiology. Volume 15. 337–348. 4 indexed citations

Hersby, Ditte Stampe, Lone Schejbel, Estrid Høgdall, et al.. (2023). Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma. Leukemia & lymphoma. 64(9). 1527–1535. 4 indexed citations

10.

Bæch, Joachim, Marianne Tang Severinsen, Henrik Frederiksen, et al.. (2022). Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy. Blood Advances. 6(15). 4427–4435. 2 indexed citations

11.

Juul, Maja Bech, Jelena Jelicic, Henriette Engberg, et al.. (2022). Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study. Leukemia & lymphoma. 63(9). 2074–2083. 1 indexed citations

12.

Jakobsen, Lasse Hjort, Marianne Tang Severinsen, Joachim Bæch, et al.. (2022). Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark. Blood Cancer Journal. 12(1). 16–16. 6 indexed citations

13.

Saini, Sunil Kumar, Ditte Stampe Hersby, Tripti Tamhane, et al.. (2021). SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 ⁺ T cell activation in COVID-19 patients. Science Immunology. 6(58). 138 indexed citations

14.

Pedersen, Mette Ølgod, Anupama Reddy, Cassandra Love, et al.. (2019). PD‐L1 expression is low in large B‐cell lymphoma with MYC or double‐hit translocation. Hematological Oncology. 37(4). 375–382. 7 indexed citations

15.

Ørskov, Andreas Due, Sunil Kumar Saini, Anne-Mette Bjerregaard, et al.. (2017). Activation of T Cells Specific to Endogenous Retroviral Peptides: Possible Association with Clinical Response to Azacitidine in Myeloid Malignancies. Blood. 130. 4243–4243. 1 indexed citations

16.

Pedersen, Mette Ølgod, Mette Ølgod Pedersen, Anne Ortved Gang, et al.. (2017). Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers. PLoS ONE. 12(10). e0186983–e0186983. 16 indexed citations

17.

Gang, Anne Ortved, Michael Pedersen, Francesco d’Amore, et al.. (2015). A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry. Leukemia & lymphoma. 56(9). 2556–2562. 20 indexed citations

18.

El‐Galaly, Tarec Christoffer, Martin Bjerregård Pedersen, Martin Hutchings, et al.. (2015). Utility of interim and end‐of‐treatment PET/CT in peripheral T‐cell lymphomas: A review of 124 patients. American Journal of Hematology. 90(11). 975–980. 43 indexed citations

19.

Pedersen, Mette Ølgod, Anne Ortved Gang, Tim Svenstrup Poulsen, et al.. (2012). MYC Translocation Partner Gene Determines Survival in Large B-Cell Lymphoma with MYC- or Double Hit MYC/BCL2 Translocation. Blood. 120(21). 542–542. 2 indexed citations

20.

Vangsted, Annette Juul, Tobias Wirenfeldt Klausen, Niels Frost Andersen, et al.. (2010). Improved survival of multiple myeloma patients with late relapse after high‐dose treatment and stem cell support, a population‐based study of 348 patients in Denmark in 1994–2004*. European Journal Of Haematology. 85(3). 209–216. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact